Why pharma manufacturers need dedicated pharma ERP software
A pharmaceutical plant runs on documents as much as on machines. Every API and excipient lot must be sampled and approved before use, every batch must follow an approved master formula, every stage must be recorded, and nothing leaves the plant until quality control has released it. When these records live in paper BMRs, Excel stock sheets and an accounting package, the plant spends a large part of each audit reconstructing what happened.
Pharma ERP software brings the material and quality trail into one system. Goods receipt puts material into quarantine, QC approval moves it to usable stock, dispensing is done against a batch, output and yield are booked stage by stage, and the finished batch stays on hold until it is released. DotOne, the platform we implement, keeps this flow linked to purchase, sales, GST and costing, so the plant and the office read the same data.
The formulation process, stage by stage in the ERP
We configure the ERP to the dosage forms you make. Each stage records input, output and loss, so yield variance is visible at the stage where it occurs.
Receipt, quarantine and sampling
Material is received against the purchase order with the manufacturer name, supplier batch, manufacturing and expiry dates. It enters a quarantine status, a sampling request goes to QC, and the material cannot be issued until it is approved with an analytical reference number.
Dispensing against batch
The batch is created from the master formula scaled to the batch size. Dispensing issues approved lots by FEFO, with potency-based quantity adjustment for APIs where required, and records the lot numbers actually used.
Granulation, blending, compression and coating
For solid orals, each stage is a step in the batch with its own output, yield and in-process check results. Liquids, ointments and capsules are configured with their own stages, such as manufacturing, filtration, filling or encapsulation.
Packing and finished goods hold
Primary and secondary packing consume printed foils, cartons and labels issued against the batch. Finished goods are booked on hold with batch number, manufacturing date and expiry until QC releases them.
GMP, Schedule M and documented control
Revised Schedule M expects a manufacturer to show control over materials, processes and records. An ERP does not make a plant compliant by itself, but it removes many of the gaps that inspections tend to find. These are the controls we usually set up:
- Status-based stock: quarantine, under test, approved, rejected and on hold, with issue blocked for anything not approved.
- Approved vendor list: material can only be bought from approved manufacturers and suppliers for that item.
- Master formula versions: batches use the current approved version, and changes go through an approval step.
- Electronic records of dispensing, stage output, yield and in-process results against each batch.
- Deviation, change control and CAPA logs linked to the batch, item or vendor they relate to.
- User-wise rights and an audit trail of who created, changed or approved each record.
Our quality management software page explains inspection plans and approval workflows in more detail.
QC release and batch traceability
Quality control sits between every receipt and every dispatch. The ERP raises inspection lots automatically for incoming material, in-process stages and finished batches, records test parameters against specifications, and moves stock to approved or rejected status only when QC signs off.
Because every issue is recorded by lot, the system builds batch genealogy as a by-product. From a market complaint, you can trace a finished batch back to the API, excipient and packing material lots used, and forward to every customer and invoice that received it. This is the basis of a recall, and the batch traceability page shows how the trace works.
Expiry, retest and FEFO stock control
Expired stock is a direct loss and a compliance risk. The ERP holds expiry and retest dates on every lot, issues stock first expiry first out by default, and blocks the use of expired or retest-due material. Near-expiry reports cover raw material, packing material and finished goods, so purchase, production and sales can act while there is still time.
For finished goods, customer-wise minimum shelf life rules can be applied at dispatch, and sales returns are received into a separate status for inspection before they are restocked or destroyed.
Loan licence, third party and job work manufacturing
Many Indian pharma units manufacture for marketing companies on a loan licence or third party basis, or send stages such as coating or packing to another unit. The ERP tracks principal-supplied material separately from own stock, records batch output against each principal, and supports job work challans with ITC-04 data where goods move under section 143. Our job work software page covers the challan flow.
Pharma costing, GST and dispatch
Batch cost is built from actual dispensed quantities at actual lot rates, plus packing material, conversion cost and the loss from yield variance and rejected batches. Management can compare cost per strip, bottle or tube with the realised price by product and customer. The method is explained on the costing software page.
At dispatch, invoices carry batch number, manufacturing and expiry dates, and the GST e-invoice and e-way bill are generated from the same document. HSN codes and GST rates sit on the item master.
What is the best ERP for pharma manufacturing?
Judge any pharma ERP software on your own products and records. Ask the vendor to show:
- Quarantine and QC approval that genuinely blocks issue of unapproved material.
- Batch creation from a versioned master formula with potency adjustment.
- Stage-wise yield and in-process results against the batch.
- Full forward and backward batch genealogy in a single report.
- FEFO issue, expiry blocking and near-expiry alerts.
- Batch details on invoices with e-invoice and e-way bill.
Our checklist on how to choose ERP software lists further questions to ask during a demo.
